egg
yolk
constitut
relev
altern
sourc
antibodi
present
advantag
mammalian
serum
immunoglobulin
regard
product
anim
welfar
specif
main
immunoglobulin
present
avian
blood
igi
transmit
offspr
accumul
egg
yolk
enabl
noninvas
harvest
high
amount
antibodi
moreov
due
structur
differ
phylogenet
distanc
igi
suitabl
diagnost
purpos
mammalian
antibodi
sinc
react
certain
compon
human
immun
system
display
greater
avid
mammalian
conserv
protein
igi
extens
use
health
research
therapeut
diagnost
tool
articl
aim
review
applic
human
veterinari
health
antibodi
protein
molecul
produc
respons
antigen
due
abil
bind
specif
target
wide
use
research
diagnosi
therapi
current
avail
antibodi
produc
mammal
especi
small
rodent
howev
product
antibodi
mammal
challeng
due
fact
antigen
elicit
weak
immun
respons
even
complet
nonimmunogen
moreov
product
antibodi
mammal
involv
procedur
caus
pain
distress
anim
immun
blood
sampl
collect
sacrific
search
effici
econom
techniqu
well
reduct
refin
use
anim
led
grow
interest
egg
yolk
antibodi
igi
obtain
antibodi
egg
yolk
noninvas
method
elimin
need
blood
collect
hen
produc
greater
amount
antibodi
compar
anim
like
rodent
exampl
consider
reduc
number
anim
requir
product
antibodi
method
present
sever
econom
advantag
use
anim
exampl
cost
maintain
hen
less
expens
maintain
anim
like
mice
rabbit
amount
antibodi
produc
chicken
also
correspond
larger
anim
goat
sheep
instanc
one
year
hen
lay
egg
produc
averag
g
igi
moreov
specif
igi
produc
chicken
total
amount
antibodi
nonetheless
amount
antibodi
produc
correl
quantiti
antigen
appli
hen
immunogen
molecular
weight
product
techniqu
well
refin
point
view
anim
welfar
igi
technolog
use
sever
purpos
human
veterinari
health
immunodiagnost
immunotherapi
neutral
toxin
venom
anim
bacteria
function
food
consid
fast
develop
igi
technolog
work
aim
review
applic
human
anim
health
addit
increas
potenti
use
antibodi
among
research
consequ
promot
reduc
use
noninvas
procedur
anim
specif
protect
effect
egg
yolk
extract
immun
hen
attribut
transfer
serum
chicken
antibodi
egg
first
describ
howev
knowledg
remain
without
applic
attract
interest
scientif
commun
due
search
anim
welfar
driven
work
russel
burch
public
principl
human
experiment
techniqu
use
igi
increas
possibl
due
develop
commerci
avail
secondari
reagent
igi
purif
kit
antiigi
specif
antibodi
conjug
alkalin
phosphatas
fluorescein
isothiocyan
peroxidas
marker
european
center
valid
altern
method
ecvam
workshop
recommend
use
igi
rather
mammalian
igg
purpos
minim
pain
gener
invas
collect
serum
antibodi
igi
present
bird
reptil
amphibian
lungfish
evolutionari
precursor
igg
ige
present
mammal
time
igi
call
igg
due
suppos
similar
two
howev
lesli
clem
emphas
distinct
differ
igi
igg
antigen
differ
major
size
igi
heavi
chain
suggest
use
term
instead
igg
igi
molecul
structur
similar
igg
two
heavi
chain
h
one
molecular
weight
kda
two
light
chain
l
kda
light
chain
one
constant
region
cl
one
variabl
region
vl
similar
igg
major
differ
igi
igg
found
heavi
chain
igg
three
constant
region
heavi
chain
igi
four
constant
region
fig
constant
domain
correspond
carbohydr
chain
give
igi
higher
molecular
weight
kda
comparison
igg
kda
igi
less
flexibl
igg
due
absenc
hing
region
similar
aspect
ige
presenc
glycin
prolin
residu
region
also
limit
igi
flexibl
one
advantag
higher
chain
stiff
may
associ
increas
igi
resist
proteolyt
degrad
fragment
also
igi
hydrophob
igg
isoelectr
point
halflif
purifi
igi
month
retain
activ
six
month
room
temperatur
one
month
moreov
affinitypurifi
biotinyl
igi
retain
high
activ
five
year
storag
structur
phylogenet
differ
igi
igg
manifest
differ
molecular
biochem
interact
fc
portion
igi
unabl
activ
human
complement
bind
rheumatoid
factor
protein
g
also
react
human
antimous
antibodi
hama
erythrocyt
agglutinogen
b
due
phylogenet
distanc
chicken
produc
stronger
immun
respons
conserv
mammalian
protein
although
igi
contain
variabl
v
junction
j
divers
region
contribut
v
j
rearrang
immunogenet
divers
small
due
fact
singl
locu
undergo
rearrang
thu
genet
divers
igi
guarante
gene
hyperconvers
process
pseudogen
donat
homolog
sequenc
function
gene
v
v
j
rearrang
even
though
protein
molecul
igi
resist
heat
ph
stabl
activ
ph
howev
affin
igi
antigen
decreas
increas
temperatur
nonetheless
addit
sucros
maltos
glycin
protect
igi
heat
denatur
sorbitol
stabil
acid
ph
igi
resist
inactiv
proteolyt
enzym
trypsin
chymotrypsin
degrad
pepsin
digest
igi
papain
lead
fc
fragment
plu
two
monoval
fab
fragment
like
igg
nonetheless
igi
digest
pepsin
lead
fragment
two
monoval
fab
fragment
unlik
mammalian
antibodi
form
one
bival
fab
fragment
cleav
pepsin
characterist
igi
comparison
igg
summar
tabl
sever
method
develop
protect
igi
degrad
ph
pepsin
present
stomach
allow
arriv
unscath
small
intestin
especi
import
use
igi
enter
pathogen
among
treatment
chitosan
algin
microcapsul
microcapsul
copolym
methacryl
acid
liposom
multipl
emulsif
hydrogel
carbon
nanotub
hydrogel
test
differ
degre
success
nonetheless
unprotect
igi
consum
egg
yolk
liquid
powder
form
show
resist
gastrointestin
tract
condit
calv
antibodi
titer
influenc
sever
factor
antigen
type
dose
use
adjuv
rout
applic
inocul
frequenc
age
stage
develop
bird
sever
protocol
obtain
igi
observ
differ
variabl
appli
basic
multipl
immun
protocol
test
differ
antigen
anim
order
obtain
highest
antibodi
titer
case
sever
antigen
type
use
produc
specif
igi
bird
complex
antigen
viru
bacteria
parasit
singl
antigen
protein
polysaccharid
peptid
nucleic
acid
differ
antigen
concentr
also
combin
adjuv
howev
common
use
antigen
per
ml
inject
two
three
site
age
hen
rang
seven
eight
week
induct
high
antibodi
titer
depend
use
adjuv
though
freund
complet
adjuv
fca
potent
induc
antibodi
laboratori
anim
lead
sever
inflamm
inject
site
although
studi
shown
immun
fca
toler
bird
mammal
seem
gener
tissu
damag
chicken
studi
use
fca
bird
immun
contradict
result
sinc
consensu
one
best
substitut
fca
freund
incomplet
adjuv
fia
unlik
fca
contain
mycobacteria
shade
et
al
recommend
use
fia
use
sinc
first
immun
without
prejudic
antibodi
titer
spite
first
inocul
gener
perform
use
fca
subsequ
inocul
perform
use
fia
without
occurr
inflamm
inject
site
common
rout
antigen
administr
igi
product
chicken
intramuscular
rout
inocul
usual
breast
muscl
techniqu
suit
young
hen
subcutan
inject
neck
difficult
perform
may
caus
distress
anim
intramuscular
inject
leg
must
avoid
lead
lame
nonetheless
noninvas
method
administr
antigen
also
perform
oral
number
inocul
requir
depend
type
dose
antigen
well
adjuv
use
least
two
inocul
must
perform
lay
period
interv
four
six
week
titer
igi
must
assess
day
last
immun
antibodi
titer
decreas
immun
must
done
entir
lay
period
increas
antibodi
titer
year
round
increas
titer
egg
yolk
antibodi
observ
second
week
sometim
fifth
week
post
antigen
inocul
steadi
increas
stabil
antibodi
titer
occur
reach
plateau
decreas
progress
booster
inocul
possibl
keep
high
titer
egg
yolk
antibodi
day
igi
extract
consist
remov
lipid
form
water
solubl
fraction
wsf
follow
precipit
antibodi
contain
therein
sever
extract
method
avail
obtain
igi
egg
yolk
choic
suitabl
method
depend
purpos
requir
differ
purif
degre
well
extract
scale
cost
avail
technolog
frequent
use
method
extract
igi
precipit
polyethylen
glycol
peg
method
consist
delipid
centrifug
egg
yolk
dilut
phosphat
buffer
salin
pb
peg
next
supernat
twice
centrifug
peg
precipit
antibodi
akita
nakai
obtain
highli
purifi
igi
remov
lipid
yolk
mean
sixfold
dilut
water
ph
incub
time
h
follow
igi
precipit
ammonium
sulfat
nh
supplement
addit
sodium
chlorid
nacl
ultrafiltr
prior
gel
filtrat
ion
exchang
chromatographi
author
also
achiev
highli
purifi
igi
mean
ethanol
precipit
lower
temperatur
nonetheless
studi
conduct
et
al
show
suit
concentr
nh
igi
precipit
studi
higher
concentr
nh
also
caus
precipit
nonspecif
protein
lower
concentr
led
greater
loss
antibodi
supernat
sinc
fc
region
igi
bind
protein
g
commonli
use
affin
purif
mammalian
igg
affin
chromatograph
method
igi
purif
requir
type
ligand
igi
purifi
adsorpt
immun
antigen
solid
phase
affin
column
gener
monospecif
antibodi
elut
acid
alkalin
condit
purif
igi
also
perform
thiophil
adsorpt
chromatographi
contrast
affin
purif
method
perform
mild
condit
hen
abl
produc
mg
igi
antibodi
yolk
specif
one
year
singl
lay
hen
produc
g
total
igi
although
product
igi
research
mainli
done
chicken
bird
also
use
purpos
goos
quail
use
immun
protocol
similar
use
chicken
product
igi
possibl
applic
human
veterinari
health
summar
fig
use
polyclon
igi
infecti
diseas
minim
risk
microbi
resist
sinc
antibodi
direct
variou
antigen
microorgan
requir
multipl
gene
synthesi
therefor
specif
igi
antibodi
relev
altern
use
antimicrobi
human
veterinari
health
face
emerg
resist
bacteria
igi
antibacteri
activ
assess
inhibit
bacteri
growth
biofilm
format
vitro
well
adhes
abil
sinc
prior
condit
success
colon
higher
anim
bacteria
virus
igi
antibacteri
activ
gastrointestin
pathogen
wide
investig
nasiri
et
al
extract
igi
hen
immun
recombin
protein
fanc
enterotoxigen
escherichia
coli
etec
antibodi
bound
specif
fanc
elisa
western
blot
dotblot
demand
thu
investig
evalu
viabil
potenti
immunotherapeut
compound
li
et
al
evalu
effect
specif
nonspecif
igi
salmonella
typhimurium
immun
respons
mice
infect
bacterium
specif
igi
reduc
express
proinflammatori
cytokin
elev
antiinflammatori
cytokin
nonspecif
igi
also
reduc
level
alter
express
level
although
specif
nonspecif
antibodi
reduc
number
lymphocyt
lamina
propria
lymphocyt
jejunum
mice
anim
treat
anti
typhimurium
igi
longer
surviv
rate
treat
nonspecif
igi
igi
activ
bacteri
spore
also
investig
oral
administr
igi
clostridium
difficil
spore
delay
onset
diarrhea
rat
treat
prior
infect
reduc
recurr
infect
rat
thu
specif
igi
could
use
prophylaxi
c
difficil
infect
well
immunotherapeut
elimin
remain
spore
intestin
peopl
alreadi
infect
would
reduc
recurr
diarrhea
therapeut
action
igi
helicobact
pylori
larg
studi
well
antibodi
direct
whole
cell
specif
protein
oral
administr
antihpuc
h
pylori
ureas
igi
inhibit
growth
h
pylori
vitro
reduc
inflamm
stomach
mice
signific
reduct
neutrophil
lymphocyt
infiltr
tissu
decreas
serum
level
antibodi
h
pylori
also
observ
treat
anim
similar
result
reduct
serum
level
antih
pylori
igg
absenc
inflamm
sign
stomach
observ
mice
receiv
oral
igi
h
pylori
vacuol
cytokin
vaca
specif
igi
hpnap
protein
main
virul
factor
h
pylori
significantli
inhibit
adhes
bacterium
ag
cell
cultur
solhi
et
al
evalu
occurr
cross
reaction
strainspecif
igi
four
differ
h
pylori
strain
antibodi
inhibit
cell
growth
ureas
enzym
strain
specif
also
strain
therapeut
potenti
igi
bacteri
respiratori
tract
infect
also
consid
igi
mycobacterium
tuberculosi
increas
prolifer
pbmc
peripher
blood
mononuclear
cell
rat
dosedepend
manner
increas
express
cytokin
stimul
cellular
immun
respons
observ
increas
mrna
level
detect
rtpcr
indic
antim
tuberculosi
igi
potenti
immunotherapeut
stimul
thelper
immun
respons
shi
et
al
produc
specif
igi
multidrug
resist
strain
acinetobact
baumannii
antibodi
inhibit
bacteri
growth
vitro
significantli
reduc
mortal
mice
infect
bacterium
attenu
lung
inflamm
igi
also
test
potenti
therapeut
resourc
oral
infect
prevotella
intermedia
specif
igi
inhibit
bacteri
growth
liquid
medium
show
therapeut
activ
rat
p
intermedia
induc
gingiv
reduct
gingiv
inflamm
bacteri
plaqu
bleed
well
normal
wbc
white
blood
cell
level
blood
observ
treat
anim
histopatholog
examin
show
sign
inflamm
gum
rat
treat
antip
intermedia
igi
addit
studi
shown
inhibitori
growth
effect
therapeut
igi
produc
fusobacterium
nucleatum
liquid
medium
format
biofilm
polyestyren
plate
antif
nucleatum
igi
also
reduc
bone
loss
mice
periodont
diseas
appli
infect
thu
present
therapeut
function
therapeut
effect
igi
acn
also
evalu
revathi
et
al
produc
assess
effici
specif
igi
bacterium
propionibacterium
acn
antibodi
inhibit
bacteri
growth
biofilm
format
vitro
prove
possibl
altern
antibiot
treatment
acn
recent
igi
test
antibacteri
effect
aquat
anim
gao
et
al
produc
igi
vibrio
spp
major
caus
death
white
shrimp
litopenaeu
vannamei
demonstr
powder
egg
yolk
contain
antivibrio
igi
significantli
reduc
mortal
white
shrimp
infect
v
harveyi
v
parahaemolyticu
indic
therapeut
igi
also
appli
aquafarm
prophylact
potenti
igi
dental
cari
wide
studi
interest
studi
carri
bachtiar
et
al
evalu
effect
soybean
milk
contain
igi
cariogen
bacterium
streptococcu
mutan
rat
anim
fed
milk
present
decreas
number
mutan
dental
biofilm
fifteen
day
milk
intak
igi
could
still
detect
saliva
research
effect
specif
igi
cellassoci
glucosyltransferas
enzym
cagtf
mutan
evalu
result
anticagtf
igi
inhibit
bacteri
adhes
vitro
suppress
oral
caviti
colon
addit
specif
igi
action
comd
protein
quorumsens
signal
receptor
mutan
also
explor
inhibit
vitro
develop
biofilm
mutan
oral
caviti
peopl
without
cari
chang
protein
express
pattern
found
bacteria
treat
anticomd
igi
protect
effect
igi
opportunist
infect
also
investig
thomsen
et
al
mean
chemiluminesc
product
reactiv
oxygen
speci
ro
polymorphonuclear
neutrophil
pmn
evalu
indic
intens
pmn
mediat
immun
respons
pseudomona
aeruginosa
vitro
well
influenc
antip
aeruginosa
igi
process
specif
igi
opson
bacterium
intensifi
cellular
immun
respons
probabl
due
recognit
igi
receptor
resembl
avian
igi
receptor
physicalchem
chang
bacterium
sinc
igi
activ
mammalian
fc
receptor
antip
aeruginosa
igi
could
use
prophylaxi
p
aeruginosa
infect
patient
cystic
fibrosi
increas
cellular
immun
respons
prophylaxi
bacteri
infect
anim
consumpt
use
igi
also
consid
specif
igi
incorpor
hydrogel
ad
carbon
nanotub
chitosan
hcnt
show
protect
activ
enterotoxigen
escherichia
coli
etec
piglet
thu
antietec
igi
incorpor
hcnt
oral
appli
could
use
prevent
intestin
infect
anim
order
gener
antibodi
bacterium
campylobact
jejuni
use
food
addit
aim
control
c
jejuni
colon
chicken
thibodeau
et
al
produc
antic
jejuni
igi
three
differ
way
oral
administr
pool
live
bacteria
four
c
jejuni
strain
subcutan
inject
extract
outer
membran
bacterium
formalin
inactiv
bacterium
hen
submit
subcutan
inocul
produc
igi
intens
although
antibodi
obtain
oral
inocul
also
show
good
activ
antic
jejuni
igi
obtain
three
way
present
bactericid
activ
vitro
igi
bacterium
aeromona
salmonicida
caus
agent
ulcer
fish
skin
ad
powder
form
water
koi
carp
cyprinu
carpio
koi
ornament
fish
rais
antia
salmonicida
antibodi
show
good
prophylact
activ
infect
small
amount
specif
igi
enough
complet
prevent
appear
skin
ulcer
healthi
fish
cohabit
sick
fish
previous
infect
salmonicida
potenti
igi
technolog
prevent
bacteri
infect
anim
could
use
need
strategi
reduc
use
antibiot
food
anim
husbandri
link
select
spread
resist
bacteri
strain
threaten
antibiot
therapeut
resourc
therapeut
potenti
igi
viral
infect
gastrointestin
tract
anim
extens
investig
oral
administr
egg
yolk
powder
rich
igi
bovin
group
rotaviru
rva
perform
calv
infect
viru
result
diseas
attenu
occur
treat
anim
reduct
period
diarrhea
hyperthermia
absenc
symptom
observ
untreat
calv
anorexia
dehydr
depress
egg
yolk
powder
enrich
antirva
igi
retain
activ
two
year
kept
anoth
studi
igi
protein
porcin
epidem
diarrhea
viru
pedv
produc
oral
administ
piglet
previous
infect
pedv
igi
reduc
sever
diarrhea
intestin
lesion
caus
pedv
infect
nullifi
mortal
piglet
due
diseas
anoth
possibl
therapeut
use
specif
igi
dengu
fever
demonstr
fink
et
al
igi
produc
goos
abl
neutral
viru
vitro
vivo
without
bind
receptor
myeloid
cell
gener
ade
antibodi
depend
enhanc
mice
protect
effect
igi
influenza
wide
studi
igi
avian
influenza
viru
extract
egg
avail
supermarket
vietnam
vaccin
chicken
viru
requir
igi
administr
intranas
mice
infect
complet
prevent
diseas
onset
result
reveal
commerci
avail
egg
produc
countri
vaccin
mandatori
constitut
consider
sourc
igi
could
use
prevent
potenti
pandem
viru
follow
rational
wallach
et
al
produc
igi
strain
influenza
viru
test
abil
neutral
homolog
heterolog
strain
vitro
prevent
infect
vivo
antibodi
inhibit
homolog
strain
seroneutr
haemagglutin
inhibit
assay
except
igi
also
inhibit
igi
appli
intranas
mice
h
infect
influenza
viru
show
prophylact
activ
thu
igi
influenza
viru
strain
could
use
nasal
oral
spray
applic
protect
individu
environ
igi
influenza
b
viru
ibv
also
test
neutral
activ
haemagglutinin
neuraminidas
present
viru
inhibit
viral
replic
vitro
appli
intranas
antiibv
igi
prevent
influenza
develop
mice
treat
prior
viru
exposur
attenu
diseas
treat
postinfect
prophylact
effect
igi
viral
infect
respiratori
tract
also
evalu
igi
and
viru
andv
caus
agent
hantaviru
pulmonari
syndrom
hp
obtain
gees
egg
inocul
anim
dna
encod
viru
envelop
glycoprotein
antiandv
igi
abl
prevent
hp
develop
recent
infect
mice
fail
appli
onset
viremia
thu
present
prophylact
nontherapeut
activ
protect
effect
igi
also
consid
viral
infect
poultri
aizenshtein
et
al
produc
egg
effici
igi
newcastl
diseas
viru
ndv
infecti
bursal
diseas
viru
ibdv
influenza
reoviru
pathogen
bird
demonstr
passiv
immun
igi
sever
virus
possibl
nonetheless
technolog
must
explor
gel
prepar
oral
use
contain
igi
candida
albican
test
tekeuchi
et
al
caus
reduct
number
colonyform
unit
cfu
oral
caviti
elderli
peopl
show
promis
prophylact
use
c
albican
oral
infect
research
specif
igi
inhibit
adhes
candida
albican
candida
glabrata
dentur
base
materi
antic
albican
igi
effect
c
albican
antic
glabrata
igi
antibodi
equal
effect
prevent
adhes
c
glabrata
sampaio
et
al
produc
high
avid
igi
protozoan
trypanosoma
evansi
neither
prophylact
action
infect
control
treat
rat
antit
evansi
igi
increas
surviv
rate
use
concomitantli
antihematozoa
drug
anoth
studi
grando
et
al
inocul
trypanosoma
cruzi
trypomastigot
hen
extract
high
amount
antit
cruzi
igi
crossreact
evansi
antigen
western
blot
show
antit
cruzi
igi
reliabl
diagnost
tool
deserv
investig
possibl
therapeut
resourc
trypanosom
infect
phylogenet
distanc
bird
mammal
ensur
stronger
immun
respons
mammalian
antigen
bird
featur
may
advantag
produc
igi
human
tumor
antigen
follow
rational
amirijavidv
et
al
produc
highli
specif
igi
sequenc
amino
acid
present
ectodomain
trail
tnfrelat
apoptosisinduc
ligand
receptor
antibodi
bound
amino
acid
sequenc
activ
receptor
human
breast
cancer
cell
act
trail
agonist
induc
apoptosi
igi
receptor
receptor
test
coupl
singl
wall
carbon
nanotub
swnt
specif
detect
receptor
surfac
cell
bind
complex
receptor
measur
raman
signal
emit
nanotub
swnt
near
infrar
absorpt
nir
use
tumor
ablat
coupl
igi
abl
kill
cell
without
need
intern
complex
cell
find
show
igi
produc
tumor
antigen
attract
altern
select
treatment
cancer
use
could
therefor
minim
side
effect
tradit
chemotherapi
igi
rais
porcin
pancreat
lipas
use
enzym
vitro
vivo
later
mice
obes
induc
high
fat
diet
oral
treat
antibodi
given
concomitantli
food
reduct
adipos
tissu
liver
fat
level
observ
well
increas
fecal
excret
triglycerid
decreas
blood
plasma
antilipas
igi
inhibit
hydrolysi
diet
fat
reduc
intestin
absorpt
show
antiobes
activ
weixu
et
al
evalu
antiallerg
effect
specif
igi
proinflammatori
cytokin
guinea
pig
induc
allerg
rhiniti
reduct
eosinophil
number
blood
nasal
bronchial
lavag
found
well
decreas
eosinophil
neutrophil
lymphocyt
infiltr
nasal
mucosa
lung
anim
treat
igi
alon
jointli
one
side
effect
occur
individu
receiv
antivenom
serum
produc
goat
sheep
hors
due
presenc
serum
protein
antivenom
serum
deriv
anim
igg
suffici
purifi
one
advantag
use
igi
antivenom
serotherapi
easili
purifi
would
minim
occurr
side
effect
due
nonspecif
protein
araujo
et
al
demonstr
properti
specif
igi
produc
antivenom
snake
genu
bothrop
sp
antibodi
neutral
pool
venom
five
bothrop
speci
show
littl
side
effect
mice
mendonza
et
al
also
produc
igi
capabl
neutral
venom
peruvian
snake
bothrop
atox
antivenom
igi
show
consider
cross
reaction
venom
bothrop
brazili
could
use
b
atox
antivenom
also
tool
research
cross
reaction
venom
differ
speci
anoth
eleg
work
andrad
et
al
produc
igi
pool
venom
snake
genu
bothrop
venom
speci
crotalu
durissu
terrificu
antivenom
igi
extract
egg
compar
hors
antivenom
igg
western
blot
result
show
specif
egg
igi
recogn
antigen
equin
antivenom
igi
coral
snake
venom
first
produc
respons
pool
venom
differ
speci
micruru
antibodi
recogn
western
blot
venom
protein
sever
snake
isozonu
surinamensi
f
fulviu
naja
kaouthia
n
pallida
bothrop
colombiensi
crotalu
durissu
cumanensi
c
vegrandi
could
therefor
use
broadspectrum
snake
antivenom
zolfagharian
dounighi
produc
igi
inocul
vipera
lebetina
snake
venom
inactiv
radiat
hen
antibodi
effect
neutral
crude
venom
vipera
lebetina
mice
antivenom
igi
also
obtain
egg
hen
immun
venom
snake
trimeresuru
albolabri
igi
recogn
western
blot
protein
present
albolabri
venom
neutral
mice
dosedepend
manner
recent
liu
et
al
extract
purifi
igi
egg
hen
inocul
venom
deinagkistrodon
actu
snake
antibodi
abl
neutral
lethal
effect
venom
bleed
edema
format
myotox
dosedepend
manner
da
rocha
et
al
produc
igi
ophidian
toxin
crotalu
durissu
terrificu
bothrop
jararaca
biti
arietan
antibodi
abl
bind
specif
compon
venom
western
blot
protect
intox
mice
obtain
ninth
inocul
author
recommend
use
small
antigen
dose
appli
success
inocul
igi
product
sinc
dose
enough
genet
alter
v
j
segment
cell
gener
immunolog
memori
howev
igi
rais
venom
snake
oxyuranu
scutellatu
less
effect
equin
igg
unabl
neutral
neurotox
coagul
effect
venom
nonetheless
result
extend
igi
produc
venom
igi
tityu
caripitensi
scorpion
venom
produc
alvarez
et
al
neutral
venom
caripitensi
also
tityu
speci
quiroga
discrepan
gonzalespongai
inactiv
hyaluronidas
enzym
facilit
toxin
spread
tissu
present
serrulatu
venom
thu
igi
rais
caripitensi
venom
could
use
broadspectrum
antiscorpion
serum
anoth
applic
igi
technolog
prophylaxi
celiac
diseas
demonstr
gujral
et
al
develop
powder
egg
yolk
formula
protect
sugar
contain
antigliadin
igi
among
formula
mannitol
eypm
retain
activ
submit
vitro
chemic
condit
analog
stomach
small
intestin
formula
igyepym
neutral
vitro
isol
gliadin
present
food
matrix
inhibit
intestin
absorpt
mice
show
promis
prevent
celiac
diseas
bobeck
et
al
use
igi
human
intestin
alkalin
phosphatas
hiap
assess
influenc
iap
increas
bioavail
phytat
phosphat
presenc
vitamin
chicken
antihiap
igi
ingest
chicken
reduc
absorpt
phytat
phosphat
suggest
although
perform
less
adequ
sevelam
chorhydr
alreadi
use
purpos
antihiap
igi
optim
prevent
phytat
phosphat
toxic
induc
consumpt
activ
form
vitamin
abil
igi
detect
viral
pathogen
gastrointestin
tract
human
anim
wide
studi
igi
rais
canin
parvoviru
viral
like
particl
cpvvlp
use
elisa
immunochromatographi
show
sensit
specif
detect
canin
parvoviru
dog
fecal
sampl
specif
igi
protein
bovin
viral
diarrhea
viru
bvdv
use
elisa
detect
pathogen
caus
diarrhea
cattl
igi
show
high
specif
recogn
bvdv
elisa
immunochromatographi
test
use
antibodi
effici
detect
bvdv
serum
sampl
cow
diarrhea
show
concord
rtpcr
respect
da
silva
et
al
use
igi
hepat
viru
hav
competit
immunoenzymat
assay
detect
antihav
igg
serum
sampl
show
satisfactori
sensit
specif
recent
igi
hav
use
detect
viru
hepat
section
infect
rhesu
monkey
mean
indirect
immunofluoresc
iif
antihva
igi
effici
commerci
avail
igg
detect
antigen
igi
also
use
detect
viral
pathogen
aquat
anim
specif
igi
softshel
turtl
system
septicemia
spheric
viru
stsssv
use
compos
later
flow
assay
detect
viru
turtl
assay
sensit
specif
detect
stsssv
infect
turtl
serum
fece
sampl
potenti
diagnosi
present
igi
rais
nucleocapsid
protein
np
coronaviru
cov
antinp
igi
use
captur
antibodi
elisa
detect
np
lower
detect
limit
picogram
level
indic
antibodi
promis
use
diagnosi
acut
respiratori
syndrom
associ
coronaviru
sarscov
sensit
enough
detect
small
amount
np
moreov
abil
igi
diagnos
dengu
fever
also
evalu
figueiredo
et
al
produc
igi
nonstructur
protein
dengu
viru
antibodi
use
compos
immunosensor
effect
electr
detect
protein
standard
sampl
could
use
dengu
diagnosi
biolog
sampl
one
studi
diagnost
potenti
igi
staphylococcu
aureu
fact
fc
portion
igg
react
staphylococc
protein
make
igi
relev
resourc
specif
detect
differ
aureu
strain
toxin
sinc
due
structur
differ
fc
portion
igi
react
protein
follow
rational
walczak
et
al
produc
igi
fibrinogen
bind
protein
efb
staphylococcu
aureu
peptid
epitop
encompass
residu
efb
protein
antiefb
antiefb
antibodi
present
high
titer
elisa
strong
avid
western
blot
show
promis
use
diagnosi
aureu
infect
anoth
elisa
test
use
igi
staphylococc
enterotoxin
b
seb
aureu
captur
antibodi
specif
ssdna
aptam
coupl
biotin
reveal
develop
mulidi
et
al
assay
effici
detect
seb
also
react
other
staphylococc
toxin
staphylococc
endotoxin
sea
c
sec
toxic
shock
syndrom
toxin
tsst
igi
rais
appli
captur
antibodi
elisa
detect
toxin
supernat
aureu
cultur
igi
show
high
specif
toxin
without
react
protein
present
aureu
strain
abil
igi
diagnos
resist
aureu
also
investig
yamada
et
al
produc
igi
penicillin
bind
protein
pbp
present
methicillin
resist
aureu
mrsa
strain
igi
use
elisa
later
flow
latex
detect
mrsa
aureu
strain
sensit
methicillin
betalactam
antibodi
mrsa
specif
react
sensit
strain
express
signific
amount
protein
among
parasit
infect
test
cakirkoc
evalu
potenti
igi
detect
protozoan
toxoplasma
gondii
produc
igi
surfac
protein
react
target
antigen
elisa
western
blot
therefor
studi
reveal
potenti
diagnost
test
toxoplasmosi
recent
igi
conjug
fluorescein
isothiocyan
detect
gondii
tachyzoit
coloni
mean
immunofluoresc
may
use
detect
protozoan
type
sampl
interest
research
indirect
elisa
use
igi
detect
cathepsin
f
cf
cystein
proteas
present
helminth
opisthorchir
viverrini
develop
assay
show
good
sensit
detect
viverrini
fecal
sampl
human
live
endem
place
howev
cross
reaction
taenia
spp
echinostoma
spp
minut
intestin
fluke
mif
observ
therefor
improv
still
made
technolog
avail
miura
et
al
produc
igi
protein
cryptosporidium
homini
protozoan
igi
bound
western
blot
c
parvum
sporozoit
fecal
sampl
indirect
immunofluoresc
suggest
igi
could
use
diagnosi
cryptosporidiosi
caus
c
homini
c
parvum
sever
author
investig
potenti
igi
detect
tumor
marker
igi
peptid
antigen
ca
commonli
use
breast
cancer
marker
use
secondari
antibodi
sandwich
elisa
aim
detect
ca
show
potenti
clinic
use
sun
et
al
produc
igi
two
portion
transmembran
glycoprotein
proxim
region
distal
region
igi
effect
detect
glycoprotein
cultur
breast
cancer
cell
immunofluoresc
section
breast
tumor
express
use
immunohistochemistri
addit
antibodi
bound
glycoprotein
elisa
western
blot
indic
igi
promis
use
breast
cancer
diagnosi
anoth
studi
et
al
develop
direct
elisa
test
use
lysat
human
malign
tumor
cell
igi
bovin
adenosin
deaminas
cada
assay
effici
detect
human
adenosin
deaminas
hada
present
tumor
cell
lysat
possibl
due
high
homolog
cada
hada
elisa
test
use
anticada
igi
could
use
diagnos
sever
type
malign
tumor
human
well
altern
current
employ
enzymat
method
detect
quantif
ada
pleural
tuberculosi
diagnosi
anoth
igi
develop
detect
prostat
specif
antigen
psa
two
peptid
fragment
protein
demonstr
specif
mark
antigen
strongli
igg
counterpart
use
western
blot
analysi
howev
antipsa
igi
unsatisfactori
sensit
appli
secondari
antibodi
indirect
elisa
thu
deserv
investig
gener
find
suggest
phylogenet
distanc
bird
mammal
ensur
stronger
immun
respons
mammalian
antigen
bird
mammal
make
product
igi
tumor
antigen
advantag
therapeut
purpos
describ
also
usag
sever
type
immunoassay
tumor
detect
human
hen
immun
umbil
cord
sera
produc
specif
igi
igg
complement
fraction
antibodi
react
fraction
configur
higher
specif
sinc
antibodi
often
crossreact
antigen
chidorodg
rbc
group
erythrocyt
antigen
abo
group
antibodi
therefor
promis
reagent
coomb
test
igi
immunoassay
use
detect
hepat
express
cytochrom
mice
treat
medicin
herb
product
deriv
plant
rich
flavonoid
metabol
wide
varieti
chemic
differ
structur
particular
small
hydrophob
compound
includ
potenti
cytotox
carcinogen
agent
igi
specif
without
react
cytochrom
abl
detect
reduct
hepat
express
due
ingest
natur
product
hepatoprotect
effect
abil
igi
identifi
harm
substanc
consum
product
evalu
elisa
test
develop
detect
staphylococc
enterotoxin
g
seg
use
specif
igi
show
satisfactori
sensit
specif
reduc
interfer
protein
occur
igg
test
test
success
use
detect
seg
milk
dairi
product
sampl
could
therefor
use
identifi
toxin
food
bittner
et
al
use
igi
elisa
detect
potenti
allergen
protein
commerci
avail
latex
glove
assay
present
similar
result
gold
standard
test
use
mammalian
igg
igi
also
use
assay
identifi
antibiot
residu
food
product
anim
origin
demonstr
studi
et
al
produc
antigentamycin
igi
specif
detect
target
antibiot
present
anim
origin
product
follow
rational
li
et
al
use
specif
igi
detect
kanamycin
gentamycin
residu
milk
meat
sampl
mean
competit
elisa
fpia
fluoresc
polar
immunoassay
potenti
igi
identifi
substanc
also
use
evalu
toxic
natur
product
employ
altern
medicin
igi
label
quantum
dot
success
use
later
flow
assay
detect
rhein
toxic
substanc
found
plant
rheum
officinal
wide
use
chines
tradit
medicin
plant
sampl
serum
user
igi
rais
bacterium
listeria
monocytogen
show
signific
inhibitori
effect
bacteri
growth
liquid
medium
fish
sampl
store
dosedepend
manner
indic
antil
monocytogen
igi
potenti
antimicrobi
use
food
industri
take
consider
versatil
rang
igi
alreadi
test
sever
bacteria
result
could
easili
appli
food
poison
bacteria
virus
among
import
technolog
leclair
et
al
demonstr
igi
produc
staphylococc
enterotoxin
b
seb
potenti
biolog
weapon
save
individu
expos
materi
result
rhesu
monkey
show
anim
receiv
antiseb
igi
min
h
exposur
lethal
seb
aerosol
surviv
indic
antiseb
igi
could
use
protect
popul
hypothet
context
bioterror
involv
seb
latest
find
use
igi
clearli
demonstr
versatil
technolog
obtain
igi
bird
present
sever
technic
econom
advantag
mammalian
igg
describ
review
igi
technolog
broad
spectrum
applic
human
veterinari
health
use
multipl
type
therapi
use
prevent
variou
type
diseas
detect
mean
differ
techniqu
sever
class
antigen
microorgan
tumor
marker
substanc
among
advantag
technolog
replac
invas
antibodi
collect
extract
egg
one
interest
consid
anim
welfar
benefit
technolog
possibl
achiev
great
quantiti
antibodi
lower
cost
product
less
damag
anim
welfar
due
structur
differ
phylogenet
distanc
igi
specif
diagnost
use
display
greater
avid
mammalian
conserv
protein
igg
thu
import
altern
search
effect
diagnost
therapi
addit
view
proven
abil
neutral
microorgan
igi
repres
import
therapeut
resourc
time
increas
resist
antibiot
emerg
viral
diseas
treatment
fund
compet
interest
report
